Clinical trial Recruiting at 1 site Interventional Ages 7 to 13

Wearability and myopia control with ZEISS MyoCare versus ZEISS single‑vision spectacle lenses

Official title: A Double Masked, Randomised, Longitudinal Comparative Study to Evaluate the Wearability and Myopia Progression of ZEISS MyoCare Spectacle Lenses Versus Two ZEISS Single Vision Spectacle Lenses in Children With Myopia

Run by ZEISS Vision Care · NCT07021560 · Data updated 2026-11-12

This test will see if ZEISS MyoCare spectacle lenses, compared with two ZEISS single‑vision lenses, slow myopia progression in children aged 7 to 13.

More Myopia trials

Quick facts

Study typeInterventional
Ages7 Years to 13 Years
SexAll
Enrollment90 (estimated)
SponsorZEISS Vision Care
Industry-sponsored
Locations1 site (Hanoi)
StatusRecruiting
StartedMay 27, 2025
Main results expectedJanuary 2026
Study endsJanuary 2026
Registry record updatedJune 15, 2025
Trial IDNCT07021560 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children 7–13 years old with myopia between −0.75 D and −5.00 D, astigmatism ≤1.50 D, anisometropia ≤1.50 D, vision correctable to at least 0.8, and a parent or guardian who can consent in Vietnamese or English.

Probably not a fit

Children with systemic or ocular diseases affecting vision, refractive errors outside the specified ranges, higher astigmatism, or who cannot comply with wearing the trial spectacles are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Children aged 7–13 with mild to moderate myopia are randomly assigned to wear one of three ZEISS spectacle lens types for six months. The protocol includes five in‑person clinic visits and two virtual follow‑ups to measure axial length, refractive error, and how well the lenses are worn. Eligible participants have cycloplegic spherical equivalent between −0.75 D and −5.00 D, astigmatism ≤1.50 D, anisometropia ≤1.50 D, and vision correctable to at least 0.8 in each eye. The trial is sponsored by ZEISS Vision Care and conducted at Hanoi Eye Hospital 2.

Why it matters

Potential benefit: If successful, the ZEISS MyoCare lenses could slow axial elongation and reduce the rate of myopia progression in participating children.

How similar studies have gone: Other peripheral‑defocus and dual‑focus spectacle lens designs have produced modest reductions in myopia progression in multiple trials, though effectiveness varies by design and patient age.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* be accompanied by a parent or guardian who is able to read and comprehend Vietnamese/English and sign a record of informed consent/assent;
* at baseline, be within the age range of 7 to 13 years old inclusive;
* be diagnosed as myopic having cycloplegic spherical equivalent between -0.75 dioptre (D) and -5.00 dioptre (D);
* astigmatism ≤1.50D;
* anisometropia of not more than 1.50D;
* be willing to comply with the wearing of clinical trial spectacles and clinical trial visit schedule as directed by the investigator;
* have ocular findings deemed to be normal;
* vision correctable to at least 0.8 or better in each eye with spectacles.

Exclusion Criteria:

* Any pre-existing systemic or ocular condition, including infection or disease that is likely to affect visual acuity and refractive error;
* Any systemic disease that adversely affects ocular health e.g. diabetes, Graves disease, and auto-immune diseases such as ankylosing spondylitis, multiple sclerosis, Sjögrens syndrome and systemic lupus erythematosus.
* Use of or a need for any systemic medication or topical medications which may alter normal ocular findings / are known to affect a participant's ocular health / physiology in an adverse or beneficial manner at enrolment and/or during the clinical trial. NB: Systemic antihistamines are allowed on an "as needed basis", provided they are not used prophylactically during the trial and at least 24 hours before the clinical trial product is used.
* History of eye trauma or eye surgery
* Amblyopia
* Anisometropia of not more than 1.50D
* Strabismus
* History of use of myopia control interventions such as Orthokeratology or atropine 3 months prior to commencement of this trial.
* Known allergy or intolerance to ingredients to cycloplegic eye-drops.
* Currently enrolled in another clinical trial.

Where it's running

  • Hanoi Eye Hospital 2
    Hanoi, Vietnam
    Recruiting

Study contacts

  • Principal investigator: Chi Hoang Viet Vu, MD — Hanoi Eye Hospital 2
  • Study coordinator: Nicole Liu, MBBS, MOptom, PhD
  • Email: xiao.liu@zeiss.com
  • Phone: +61 413759820

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.